Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial

Diabetologia
Christoph KapitzaAnne Flint

Abstract

Semaglutide is a glucagon-like peptide-1 analogue in development for the treatment of type 2 diabetes. Its effects on first- and second-phase insulin secretion and other measures of beta cell function and glycaemic control were assessed. In this single-centre, double-blind, placebo-controlled, parallel-group trial, conducted at the Profil Institut für Stoffwechselforschung, Germany, 75 adult (aged 18-64 years) participants with type 2 diabetes (eligibility: HbA1c of 6.5-9.0% (47.5-74.9 mmol/mol); BMI 20.0-35.0 kg/m2; and treatment with diet and exercise and/or metformin monotherapy with a dose unchanged in the 30 days prior to screening) were randomised (1:1) to once-weekly s.c. semaglutide 1.0 mg (0.25, 0.5, 1.0 mg escalated) or placebo for 12 weeks. Co-primary endpoints were changes from baseline to end of treatment in the first (AUC0-10 min) and second (AUC10-120 min) insulin secretion phases, as measured by the IVGTT. An arginine stimulation test (AST) and a 24 h meal stimulation test were also conducted. A graded glucose infusion test (GGIT) assessed insulin secretion rate (ISR) in treated participants and a group of untreated healthy participants. Safety endpoints were also assessed. In total, 37 participants received sem...Continue Reading

References

Aug 1, 1996·Computer Methods and Programs in Biomedicine·R HovorkaM A Young
Mar 21, 1998·The Journal of Clinical Investigation·A FlintJ J Holst
Apr 28, 2005·Diabetes Care·UNKNOWN Workgroup on Hypoglycemia, American Diabetes Association
Jun 28, 2007·International Journal of Clinical Practice. Supplement·E Standl
Apr 25, 2013·Diabetes Care·Chinmay S MaratheMichael Horowitz
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Jun 6, 2012·Journal of Diabetes Investigation·Junji KozawaIichiro Shimomura
Feb 25, 2015·Experimental Biology and Medicine·Juan ZhengLu-Lu Chen
Aug 27, 2015·Journal of Medicinal Chemistry·Jesper LauThomas Kruse
Oct 30, 2015·Diabetes, Obesity & Metabolism·Sten Madsbad
Dec 2, 2015·Biomedical Reports·Yoshiko MurakataYoshiji Yamada
Jan 26, 2016·Clinical Diabetes : a Publication of the American Diabetes Association·UNKNOWN American Diabetes Association
Apr 12, 2016·Trends in Endocrinology and Metabolism : TEM·Eva TuduríRubén Nogueiras

❮ Previous
Next ❯

Citations

May 15, 2018·Diabetes, Obesity & Metabolism·Panagiotis AndreadisApostolos Tsapas
Jun 14, 2018·Expert Opinion on Drug Metabolism & Toxicology·Tine A BækdalCilie W Hansen
Oct 9, 2018·Expert Review of Clinical Pharmacology·Scott A CoonJustinne E Guyton
Feb 16, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Georgios A ChristouDimitrios N Kiortsis
Feb 23, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rune V OvergaardSteen H Ingwersen
Apr 3, 2019·The Journal of Clinical Endocrinology and Metabolism·Vivian A FonsecaJochen Seufert
Aug 5, 2017·Expert Opinion on Drug Delivery·Kathleen H Ang, Jennifer L Sherr
Nov 7, 2019·American Journal of Therapeutics·Angela Napoli
Jan 25, 2018·Drugs·Sohita Dhillon
Feb 15, 2018·Expert Opinion on Drug Metabolism & Toxicology·Sheila A Doggrell
Feb 13, 2018·Expert Opinion on Biological Therapy·Maka S HedringtonStephen N Davis
May 26, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Valentin DemmelAnne Flint
Apr 30, 2019·Frontiers in Endocrinology·Lotte Bjerre Knudsen, Jesper Lau

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation

Software Mentioned

ISEC

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.